Canagen India Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 8.59%
- Ebitda 8.60%
- Net Worth -94.48%
- Total Assets 691.75%
About Canagen India Pharmaceuticals
Canagen India Pharmaceuticals Private Limited (CIPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 2018 (Six years and four months 22 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suren Mankani, Niket Mestry, and Shubhangi Mestry serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC313857
- Company No.
313857
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Canagen India Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niket Mestry  | Managing Director | 11-Sep-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suren Mankani | Additional Director | 20-Dec-2021 | Current |
| Shubhangi Mestry | Director | 11-Sep-2018 | Current |
Financial Performance of Canagen India Pharmaceuticals.
Canagen India Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 8.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 94.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Canagen India Pharmaceuticals?
In 2020, Canagen India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oar Earth Crust Minerals Private LimitedSuren Mankani is a mutual person
- Kiearra Tiles Private Limited
Suren Mankani is a mutual person
- Miracle Potions Private Limited
Niket Mestry and Shubhangi Mestry are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Canagen India Pharmaceuticals?
Unlock and access historical data on people associated with Canagen India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Canagen India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canagen India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
